UBE2M and prostate carcinoma: Additionally, we observed that the expression of SNHG17, UBE2M, and OTUB1 was significantly correlated with a decreased infiltrating level of immune cells, indicating the immunological role of SNHG17 and its ceRNA regulatory network in prostate cancer.